ClinicalTrials.Veeva

Menu

Before and After Erythrocyte Suspension Transfusion

A

Afyonkarahisar Health Sciences University

Status

Completed

Conditions

Anemia
Oxidative Stress

Treatments

Other: Before Erythrocyte Suspension (ES)
Other: After Erythrocyte Suspension (ES)

Study type

Interventional

Funder types

Other

Identifiers

NCT04212819
2015/7-165

Details and patient eligibility

About

Hypoperfusion, hypoxia and ischemia occurs in circulation as a result of anemia. All of these situations lead to oxidative stress and endothelial dysfunction in the organism. In this study, the investigators aimed to investigate the oxidant-antioxidant balance and asymmetric dimethylarginine (ADMA) levels in patients that have symptomatic anemia in need of erythrocyte suspension (ES) transfusion. To the best of the investigators knowledge, there have been few studies in the literature on anemia and total oxidant, total antioxidant and ADMA levels. We aimed to observe changes in oxidative - antioxidant ADMA levels before and after ES transfusion.

Enrollment

50 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Only patients with deep anemia and anemia due to gastrointestinal bleeding patients in need of erythrocyte suspension transfusion were included.

Exclusion criteria

  • Patients with history of hypertension, diabetes, coronary artery disease, congestive heart failure, chronic renal failure, liver failure were not included to the study

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

50 participants in 2 patient groups

Before erythrocyte suspension (ES) transfusion group
Experimental group
Description:
50 (Female/Male: 25/25) patients were included in this study. Total antioxidant status (TAS), total oxidant status (TOS) and ADMA levels were measured from the patients after diagnoses of anemia.
Treatment:
Other: Before Erythrocyte Suspension (ES)
After erythrocyte suspension transfusion group
Experimental group
Description:
24 hours after ES transfusion, total antioxidant status (TAS), total oxidant status (TOS) and ADMA levels were measured from the patients.
Treatment:
Other: After Erythrocyte Suspension (ES)

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems